Measles, commonly known as rubeola, is a highly infectious, preventable febrile viral infection. It is still a significant source of worldwide mortality and morbidity, notably in Southeast Asia and Africa. Despite the availability of effective vaccination, it causes over 100,000 fatalities each year.
Officials declared measles eliminated in the United States in 2000, after one year of no continuous disease transmission, and from the Americas area in 2016. However, outbreaks continue to occur in the community due to illnesses and transmission among unvaccinated juveniles.
Epidemiology
Measles epidemiology varies around the globe and is linked to vaccination levels attained in a given location. Before implementing comprehensive immunization programs, measles was responsible for an estimated 2.6 million fatalities. Despite immunization in the modern period, the World Health Organization recorded 134,200 fatalities (15 deaths per hour) from measles in 2015.
The measles virus has no animal reservoir and exclusively affects humans. The virus is highly infectious, with each case having the potential to cause 14 to 18 secondary infections among susceptible populations. Measles is spread by respiratory droplets, particle aerosols, and intimate contact. Although more extended periods have been documented, the incubation period is 10 to 14 days.
Young children are most frequently affected by measles, which is highly contagious among unvaccinated and pregnant women. Due to rising vaccination coverage rates and changes in the levels of population immunity at various ages, there has been a recent transition to older kids
Anatomy
Pathophysiology
The virus infects the dendritic cells, lymphocytes, and alveolar macrophages of the respiratory tract. Later, it spreads throughout the circulation, causing viremia, before migrating to distant organs and adjacent lymphoid tissue. When a person coughs or sneezes, the virus in their lymphocytes and dendritic cells spreads to their respiratory tract epithelial cells, cleared and discharged as respiratory droplets, infecting others and continuing the cycle.
The early inflammation causes cough, coryza, and conjunctivitis. The onset of fever and the growth of viremia are related. Following spread, lymphocytic and perivascular infiltrates induce a cutaneous rash. The measles virus suppresses interferon production during the prodromal phase by using its nonstructural proteins, C and V, to lower host immunity. The escalating viral replication then induces humoral and cellular immune responses.
antibody production, which may be detected three to four days after the rash first emerges and last for six to eight weeks, makes up the early humoral reaction. IgG antibodies are subsequently generated, mainly against the viral nucleoprotein. Increased plasma levels of Th1-dependent interferon-gamma during the acute phase and subsequent increases in Th2-dependent interleukin 4, interleukin 13 levels, and interleukin 10 cellular immune responses are crucial for recovery. The typical Warthin-Finkeldey large cells in lymph node biopsy are seen against a paracortical hyperplasia background.
Immunosuppression brought on by the measles virus has been reported to endure for weeks, months, or even years. Due to this, individuals are more vulnerable to bacterial and other secondary illnesses. Due to the host’s increased vulnerability to subsequent infections, this causes the majority of the morbidity and death related to measles. The neutralizing IgG antibodies provide lifelong protection against hemagglutinin, which prevents host cell receptors from attaching to the virus.
Etiology
The causative agent is the measles virus, a member of the Paramyxoviridae family and genus. It is a negative-sense RNA virus that is nonsegmented, single-stranded, and enclosed. Six structural proteins and two non-structural proteins, C and V, are both encoded by the genome. The structural proteins are haemagglutinin (HA), matrix, large protein, nucleoprotein, and phosphoprotein. The virus attaches to the host cell via the HA protein.
Passive antibody transfer protects young children delivered to women with acquired immunity against measles, but when these antibodies diminish, they become vulnerable. The four days before and four days after the rash appears are when an infection is most contagious, coinciding with the highest viremia levels and the symptoms of cough, conjunctivitis, and coryza.
Genetics
Prognostic Factors
There is a risk of a poor prognosis, even though many individuals with measles will recover without any complications. Otitis media and diarrhea are two typical side effects of measles infection. Otitis media may result in hearing loss.
Infants and young children under the age of five, individuals over the age of 20, pregnant women, and those with impaired immune systems are more prone to experience serious consequences.
1 in 1000 infected children may develop encephalitis, and 1-2 of all infected children may die from measles-related neurologic or respiratory difficulties.
Measles, commonly known as rubeola, is a highly infectious, preventable febrile viral infection. It is still a significant source of worldwide mortality and morbidity, notably in Southeast Asia and Africa. Despite the availability of effective vaccination, it causes over 100,000 fatalities each year.
Officials declared measles eliminated in the United States in 2000, after one year of no continuous disease transmission, and from the Americas area in 2016. However, outbreaks continue to occur in the community due to illnesses and transmission among unvaccinated juveniles.
Measles epidemiology varies around the globe and is linked to vaccination levels attained in a given location. Before implementing comprehensive immunization programs, measles was responsible for an estimated 2.6 million fatalities. Despite immunization in the modern period, the World Health Organization recorded 134,200 fatalities (15 deaths per hour) from measles in 2015.
The measles virus has no animal reservoir and exclusively affects humans. The virus is highly infectious, with each case having the potential to cause 14 to 18 secondary infections among susceptible populations. Measles is spread by respiratory droplets, particle aerosols, and intimate contact. Although more extended periods have been documented, the incubation period is 10 to 14 days.
Young children are most frequently affected by measles, which is highly contagious among unvaccinated and pregnant women. Due to rising vaccination coverage rates and changes in the levels of population immunity at various ages, there has been a recent transition to older kids
The virus infects the dendritic cells, lymphocytes, and alveolar macrophages of the respiratory tract. Later, it spreads throughout the circulation, causing viremia, before migrating to distant organs and adjacent lymphoid tissue. When a person coughs or sneezes, the virus in their lymphocytes and dendritic cells spreads to their respiratory tract epithelial cells, cleared and discharged as respiratory droplets, infecting others and continuing the cycle.
The early inflammation causes cough, coryza, and conjunctivitis. The onset of fever and the growth of viremia are related. Following spread, lymphocytic and perivascular infiltrates induce a cutaneous rash. The measles virus suppresses interferon production during the prodromal phase by using its nonstructural proteins, C and V, to lower host immunity. The escalating viral replication then induces humoral and cellular immune responses.
antibody production, which may be detected three to four days after the rash first emerges and last for six to eight weeks, makes up the early humoral reaction. IgG antibodies are subsequently generated, mainly against the viral nucleoprotein. Increased plasma levels of Th1-dependent interferon-gamma during the acute phase and subsequent increases in Th2-dependent interleukin 4, interleukin 13 levels, and interleukin 10 cellular immune responses are crucial for recovery. The typical Warthin-Finkeldey large cells in lymph node biopsy are seen against a paracortical hyperplasia background.
Immunosuppression brought on by the measles virus has been reported to endure for weeks, months, or even years. Due to this, individuals are more vulnerable to bacterial and other secondary illnesses. Due to the host’s increased vulnerability to subsequent infections, this causes the majority of the morbidity and death related to measles. The neutralizing IgG antibodies provide lifelong protection against hemagglutinin, which prevents host cell receptors from attaching to the virus.
The causative agent is the measles virus, a member of the Paramyxoviridae family and genus. It is a negative-sense RNA virus that is nonsegmented, single-stranded, and enclosed. Six structural proteins and two non-structural proteins, C and V, are both encoded by the genome. The structural proteins are haemagglutinin (HA), matrix, large protein, nucleoprotein, and phosphoprotein. The virus attaches to the host cell via the HA protein.
Passive antibody transfer protects young children delivered to women with acquired immunity against measles, but when these antibodies diminish, they become vulnerable. The four days before and four days after the rash appears are when an infection is most contagious, coinciding with the highest viremia levels and the symptoms of cough, conjunctivitis, and coryza.
There is a risk of a poor prognosis, even though many individuals with measles will recover without any complications. Otitis media and diarrhea are two typical side effects of measles infection. Otitis media may result in hearing loss.
Infants and young children under the age of five, individuals over the age of 20, pregnant women, and those with impaired immune systems are more prone to experience serious consequences.
1 in 1000 infected children may develop encephalitis, and 1-2 of all infected children may die from measles-related neurologic or respiratory difficulties.
Measles, commonly known as rubeola, is a highly infectious, preventable febrile viral infection. It is still a significant source of worldwide mortality and morbidity, notably in Southeast Asia and Africa. Despite the availability of effective vaccination, it causes over 100,000 fatalities each year.
Officials declared measles eliminated in the United States in 2000, after one year of no continuous disease transmission, and from the Americas area in 2016. However, outbreaks continue to occur in the community due to illnesses and transmission among unvaccinated juveniles.
Measles epidemiology varies around the globe and is linked to vaccination levels attained in a given location. Before implementing comprehensive immunization programs, measles was responsible for an estimated 2.6 million fatalities. Despite immunization in the modern period, the World Health Organization recorded 134,200 fatalities (15 deaths per hour) from measles in 2015.
The measles virus has no animal reservoir and exclusively affects humans. The virus is highly infectious, with each case having the potential to cause 14 to 18 secondary infections among susceptible populations. Measles is spread by respiratory droplets, particle aerosols, and intimate contact. Although more extended periods have been documented, the incubation period is 10 to 14 days.
Young children are most frequently affected by measles, which is highly contagious among unvaccinated and pregnant women. Due to rising vaccination coverage rates and changes in the levels of population immunity at various ages, there has been a recent transition to older kids
The virus infects the dendritic cells, lymphocytes, and alveolar macrophages of the respiratory tract. Later, it spreads throughout the circulation, causing viremia, before migrating to distant organs and adjacent lymphoid tissue. When a person coughs or sneezes, the virus in their lymphocytes and dendritic cells spreads to their respiratory tract epithelial cells, cleared and discharged as respiratory droplets, infecting others and continuing the cycle.
The early inflammation causes cough, coryza, and conjunctivitis. The onset of fever and the growth of viremia are related. Following spread, lymphocytic and perivascular infiltrates induce a cutaneous rash. The measles virus suppresses interferon production during the prodromal phase by using its nonstructural proteins, C and V, to lower host immunity. The escalating viral replication then induces humoral and cellular immune responses.
antibody production, which may be detected three to four days after the rash first emerges and last for six to eight weeks, makes up the early humoral reaction. IgG antibodies are subsequently generated, mainly against the viral nucleoprotein. Increased plasma levels of Th1-dependent interferon-gamma during the acute phase and subsequent increases in Th2-dependent interleukin 4, interleukin 13 levels, and interleukin 10 cellular immune responses are crucial for recovery. The typical Warthin-Finkeldey large cells in lymph node biopsy are seen against a paracortical hyperplasia background.
Immunosuppression brought on by the measles virus has been reported to endure for weeks, months, or even years. Due to this, individuals are more vulnerable to bacterial and other secondary illnesses. Due to the host’s increased vulnerability to subsequent infections, this causes the majority of the morbidity and death related to measles. The neutralizing IgG antibodies provide lifelong protection against hemagglutinin, which prevents host cell receptors from attaching to the virus.
The causative agent is the measles virus, a member of the Paramyxoviridae family and genus. It is a negative-sense RNA virus that is nonsegmented, single-stranded, and enclosed. Six structural proteins and two non-structural proteins, C and V, are both encoded by the genome. The structural proteins are haemagglutinin (HA), matrix, large protein, nucleoprotein, and phosphoprotein. The virus attaches to the host cell via the HA protein.
Passive antibody transfer protects young children delivered to women with acquired immunity against measles, but when these antibodies diminish, they become vulnerable. The four days before and four days after the rash appears are when an infection is most contagious, coinciding with the highest viremia levels and the symptoms of cough, conjunctivitis, and coryza.
There is a risk of a poor prognosis, even though many individuals with measles will recover without any complications. Otitis media and diarrhea are two typical side effects of measles infection. Otitis media may result in hearing loss.
Infants and young children under the age of five, individuals over the age of 20, pregnant women, and those with impaired immune systems are more prone to experience serious consequences.
1 in 1000 infected children may develop encephalitis, and 1-2 of all infected children may die from measles-related neurologic or respiratory difficulties.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
